Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the dengue treatment market grown over the years?

The scale of the dengue treatment market has seen substantial growth over the past several years. It’s projected that it will escalate from $2.10 billion in 2024 to $2.35 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this historical growth include enhancements in diagnostic tools, the input of government and non-profit organizations, the presence of epidemiological surveillance systems, heavy investments in research and development, and initiatives for community education.

What Is the forecasted market size and growth rate for the dengue treatment market?

In the coming years, the market size for dengue treatment is anticipated to experience rapid expansion. By 2029, it is projected to rise to $3.64 billion with a compound annual growth rate (CAGR) of 11.6%. The expected growth during this forecast period can be credited to the development of universal vaccines, greater availability of vaccines, collaborations between public and private sectors, the rise of telemedicine and improvements in policy frameworks. Notable trends for the future include next-generation dengue vaccines, the use of artificial intelligence in drug discovery, intelligent tracking tools, 3D-printed vaccines, and the use of CRISPR for targeting viruses.

Get your dengue treatment market report here!

https://www.thebusinessresearchcompany.com/report/dengue-treatment-global-market-report

What are the major factors driving growth in the dengue treatment market?

The escalating rate of dengue occurrence is poised to fuel the surge of the dengue treatment market. Dengue is a viral infection transmitted by mosquitoes, which can lead to serious complications if not promptly treated. The surge in dengue occurrence rates can be attributed to increased urbanization, climate changes which facilitate mosquito reproduction, failure of vector control procedures, and population increase in high-risk zones. Dengue treatment aids in reducing the rate of dengue incidents by enabling prompt medical interventions, mitigating severe symptoms, forestalling complications, and restricting the spread of the disease via improved patient results and heightened public health awareness. For instance, a report from the Centers for Disease Control and Prevention, a government agency in the US, stated that in 2023, the number of dengue fever instances in the Americas escalated to beyond 4.6 million, with around 4,000 fatalities, denoting a 13% surge from the corresponding period in 2022 and a substantial escalation from previous years. Thus, the escalating dengue occurrence rate is propelling the surge of the dengue treatment market.

What key areas define the segmentation of the global dengue treatment Market?

The dengue treatment market covered in this report is segmented –

1) By Type: Vaccines, Acetaminophen

2) By Route Of Administration: Parenteral, Oral

3) By Drug Class: Nsaids, Antibiotics, Corticosteroids

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospital, Specialty Clinics, Home Healthcare

Subsegments:

1) By Vaccines: Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines

2) By Acetaminophen: Oral Acetaminophen, Intravenous Acetaminophen

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20745&type=smp

What are the top market players propelling the growth of the dengue treatment industry?

Major companies operating in the dengue treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi S.A., Abbott Laboratories, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Cipla Incorporated, Emergent BioSolutions Inc., Bharat Biotech International Limited, Inovio Pharmaceuticals Inc., Gennova Biopharmaceuticals Ltd., ABIVAX S.A., Cadila Healthcare Limited, Biological E. Limited

What emerging trends are influencing the growth of the dengue treatment market?

Major companies operating in the dengue treatment market are focusing on developing solutions such as broad-spectrum antiviral drugs to enhance treatment efficacy, reduce disease severity, and address multiple serotypes of the dengue virus simultaneously. A broad-spectrum antiviral drug refers to a medication that is effective against a wide range of viruses, rather than targeting a specific virus. For instance, in September 2024, Hyundai Pharmaceutical Co. Ltd., a South Korea-based manufacturer of pharmaceutical products, launched XAFTY, a groundbreaking broad-spectrum antiviral designed to treat multiple viral infections, including COVID-19, and dengue fever. It offers unique features such as an innovative drug that enhances the absorption and effectiveness of niclosamide, proven safety and efficacy demonstrated in clinical trials, the ability to target a range of RNA viruses, providing versatility against potential future threats, and a rapid response potential that allows for expedited supply to regions facing public health crises.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20745

What regions are dominating the dengue treatment market growth?

Asia-Pacific was the largest region in the dengue treatment in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

AI-Based Fever Detection Camera Global Market Report 2025

https://thebusinessresearchcompany.com/report/ai-based-fever-detection-camera-global-market-report

Injection Molding Polyamide 6 Global Market Report 2025

https://thebusinessresearchcompany.com/report/virus-filtration-global-market-report

Herpes Simplex Virus Treatment Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/herpes-simplex-virus-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: